Karina Kuczka

发表

Phenotypic differences of human neutrophils of carriers of the PSGL-1 A and B-allele in binding to immobilised P-selectin under flow conditions.

S. Harder, U. Klinkhardt, K. Lang, 2011, Thrombosis research.

The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib.

H. Deckmyn, K. Scholich, S. Harder, 2011, Blood.

Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo.

P. Gute, S. Harder, C. Angioni, 2007, The Journal of antimicrobial chemotherapy.

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

S. Harder, U. Klinkhardt, B. Picard-Willems, 2015, Platelets.

Analgesic efficacy of tramadol, pregabalin and ibuprofen in menthol-evoked cold hyperalgesia

J. Lötsch, G. Geisslinger, I. Tegeder, 2009, PAIN®.

Anti-GPVI Fab SAR264565 effectively blocks GPVI function in ex vivo human platelets under arterial shear in a perfusion chamber

S. Harder, P. Wonerow, P. Florian, 2017, European Journal of Clinical Pharmacology.

Increased Bioavailability of 11‐Keto‐β‐Boswellic Acid Following Single Oral Dose Frankincense Extract Administration After a Standardized Meal in Healthy Male Volunteers: Modeling and Simulation Considerations for Evaluating Drug Exposures

O. Werz, J. Barrett, T. Rossmanith, 2012, Journal of clinical pharmacology.

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.

S. Harder, U. Klinkhardt, K. Kuczka, 2003, Thrombosis research.

Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.

S. Staszewski, P. Gute, S. Harder, 2008, The Journal of antimicrobial chemotherapy.